{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By REYNOLDS HOLDING", "person": [{"rank": 1, "role": "reported", "firstname": "Reynolds", "organization": "", "lastname": "HOLDING"}]}, "abstract": null, "type_of_material": "News", "word_count": "373", "lead_paragraph": "The drug maker sued its former lawyers at Kirkland & Ellis over advising Teva. The lawyers say Mylan agreed, but a court may rule such waivers unethical.", "pub_date": "2015-05-05T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Mylan Case Puts Focus on Waivers", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "snippet": "The drug maker sued its former lawyers at Kirkland & Ellis over advising Teva. The lawyers say Mylan agreed, but a court may rule such waivers unethical.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/05/05/business/dealbook/mylan-case-puts-focus-on-waivers.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Suits and Litigation (Civil)", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Kirkland & Ellis", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Mylan Inc", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}], "blog": [], "_id": "5547c2db38f0d81a8df26525", "source": "The New York Times"}